IHS Chemical Week

Regions :: Western Europe :: Germany

Secondary Buyout for Specialty Firm

1:38 PM MDT | January 17, 2007 | Chemical Week Editorial Staff

Axa Private Equity (Paris) has acquired more than 70% of specialty chemicals producer Cabb (Sulzbach, Germany) from private equity firm Gilde (Utrecht, the Netherlands). The rest is held by Cabb’s management. Cabb makes monochloroacetic acid and a range of specialty intermediates, and has sales of €140 million/year ($182 million). Its production is at Gersthofen and Knapsack, Germany. Gilde bought the business from Clariant in 2005. Cabb is Axa’s second specialties acquisition in the space of six months following the purchase of Eliokem...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa